Retour
Fourchette du Jour
11,89 €
12,14 €
Fourchette 52 Semaines
6,69 €
15,42 €
Volume
1 509 954
Moyenne 50J / 200J
13,66 €
/
10,91 €
Clôture Précédente
11,83 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 52,1 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 2,4 | 3,8 |
| Rev Growth 5Y % | 9,6 | 10,0 |
| D/E | — | 0,2 |
Points Clés
Revenue grew 9,58% annually over 5 years — modest growth
Generating 269,93M in free cash flow
P/E of 52,05 — premium valuation
Cash machine — converts 374,60% of earnings into free cash flow
Capital efficient — spends only 2,32% of revenue on capex
Interest coverage of 1,75× — tight debt servicing
Croissance
Revenue Growth (5Y)
9,58%
Revenue (1Y)8,05%
Earnings (1Y)N/A
FCF Growth (3Y)-1,18%
Qualité
Return on Equity
N/A
ROIC11,90%
Net Margin2,39%
Op. Margin14,02%
Sécurité
Debt / Equity
N/A
Current Ratio2,17
Interest Coverage1,75
Valorisation
P/E Ratio
52,05
P/B RatioN/A
EV/EBITDA14,60
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,05% | Revenue Growth (3Y) | 12,30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,58% | Earnings Growth (5Y) | 61,38% |
| Profitability | |||
| Revenue (TTM) | 3,02B | Net Income (TTM) | 72,06M |
| ROE | N/A | ROA | 1,96% |
| Gross Margin | 37,63% | Operating Margin | 14,02% |
| Net Margin | 2,39% | Free Cash Flow (TTM) | 269,93M |
| ROIC | 11,90% | FCF Growth (3Y) | -1,18% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,17 |
| Interest Coverage | 1,75 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 52,05 | P/B Ratio | N/A |
| P/S Ratio | 1,24 | PEG Ratio | -0,34 |
| EV/EBITDA | 14,60 | Dividend Yield | 0,00% |
| Market Cap | 3,75B | Enterprise Value | 6,18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,02B | 2,79B | 2,39B | 2,21B | 2,09B |
| Net Income | 72,06M | -116,89M | -83,99M | -129,99M | 10,62M |
| EPS (Diluted) | 0,22 | -0,38 | -0,48 | -0,86 | 0,07 |
| Gross Profit | 1,14B | 1,02B | 863,87M | 791,46M | 768,97M |
| Operating Income | 423,09M | 249,33M | 204,37M | -94,93M | 152,72M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,68B | 3,50B | 3,47B | 3,80B | 3,94B |
| Total Liabilities | 3,67B | 3,55B | 3,41B | 3,59B | 3,57B |
| Shareholders' Equity | -70,79M | -109,27M | 19,78M | 298,42M | 360,34M |
| Total Debt | 2,74B | 2,59B | 2,75B | 2,85B | 2,88B |
| Cash & Equivalents | 310,87M | 110,55M | 91,54M | 25,98M | 247,79M |
| Current Assets | 1,91B | 1,59B | 1,38B | 1,41B | 1,52B |
| Current Liabilities | 881,63M | 1,13B | 846,60M | 752,80M | 677,24M |